Ligand validation:8DNJ

U4U: 1-[(5S,9P,12aR)-9-(2-chloro-6-hydroxyphenyl)-8-ethynyl-10-fluoro-3,4,12,12a-tetrahydro-6H-pyrazino[2,1-c][1,4]benzoxazepin-2(1H)-yl]propan-1-one

U4U is a Ligand Of Interest in 8DNJ designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8DNJ_U4U_B_303	67%	28%	0.106	0.914	1.12	1.87	2	9	0	0	100%	1
8DNJ_U4U_A_303	58%	28%	0.117	0.897	1.02	1.99	1	12	0	0	100%	1
8DNJ_U4U_C_303	37%	27%	0.138	0.834	1.11	1.95	1	10	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.